Marker Therapeutics Competitors and Similar CompaniesClear all
Marker Therapeutics's competitors and similar companies include ImmunoCellular Therapeutics.
 Marker Therapeutics Marker Therapeutics is a biopharmaceutical company engaged in the discovery and development of immunotherapeutics for the treatment of cancer, infectious diseases, autoimmune disorders, and transplant tissue rejection. |  ImmunoCellular Therapeutics ImmunoCellular Therapeutics is a clinical-stage biotechnology company developing immune-based therapies for the treatment of various cancers. | |
Founding Date | Founding Date 2018 | Founding Date 2006 |
Type | Type Public | Type Public |
Tags | ||
Locations | Locations Houston, US HQ | Locations Calabasas, US HQ |
Employees | Employees 888% decrease | Employees 357% decrease |
Valuation ($) | Valuation ($) 36.5 m | Valuation ($) 15.9 m |
Financial | ||
Revenue (est.) | Revenue (est.) $3.5m (FY, 2025) | Revenue (est.) N/A |
Net income | Net income ($12.2m) (FY, 2025) | Net income ($14.3m) (FY, 2017) |
For sources of this data, please see the company profile
View Company Profiles
ImmunoCellular Therapeutics
HQ
Calabasas, US
Employees
3
ImmunoCellular Therapeutics is a clinical-stage biotechnology company developing immune-based therapies for the treatment of various cancers.
View company